Concorde Asset Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Concorde Asset Management's LLY Position: Q1 2026 in Review
Concorde Asset Management reduced its Eli Lilly (LLY) stake by 29% in Q1 2026, selling an estimated $259K and leaving 635 shares worth $584K. The position accounts for 0.29% of the portfolio, ranked #78.
Concorde Asset Management first reported a position in LLY in Q4 2014 and has held it in 19 quarters since. The position peaked at $1.01M in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Concorde Asset Management held 635 shares of Eli Lilly worth $584K as of Q1 2026.
- Concorde Asset Management sold 255 Eli Lilly shares in Q1 2026, an estimated $259K.
- Eli Lilly made up 0.29% of Concorde Asset Management's portfolio in Q1 2026, its #78 holding.
- Concorde Asset Management first reported a position in Eli Lilly in Q4 2014 and has held it in 19 quarters since.
- Concorde Asset Management's Eli Lilly position peaked at $1.01M in Q2 2024.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Concorde Asset Management's 13F filing for Q1 2026, filed 1 Jun 2026.